ArticlePatient preference and adherence2026
Factors Associated with the Acceptance of Weight Loss Drugs Among Overweight and Obese Adults in Mainland China: A Cross-Sectional Study.
Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: With the growing burden of overweight and obesity, weight-loss pharmacotherapy has emerged as an effective treatment option. However, patient acceptance remains a significant barrier to treatment uptake and adherence. This study investigated the acceptance of weight loss drugs (WLDs) among overweight and obese adults in mainland China, as well as related social-demographic, clinical, and psychosocial determinants. Methods: Data were drawn from the 2021 Psychology and Behaviour Investigation of Chinese Residents (PBICR) study, including 2577 Chinese adults with BMI ≥24 kg/m Results: Higher family income, social support, and anxiety levels were positively correlated with the acceptance of weight loss drugs. Age ≥ 60 years, comorbidities, smoking, better dietary behaviors, and poorer family health were negatively correlated with acceptance. Acceptance of WLDs varied across occupational groups and weight status categories. Dietary behaviors were also positively correlated with acceptance. Subgroup analysis showed significant heterogeneity in the influencing factors. Conclusion: This study revealed low acceptance of WLDs among adults with overweight and obesity in mainland China. Acceptance is closely related to a variety of social demographic, clinical, and psychosocial factors. These findings highlight personalized treatment plans for obesity medications to enhance treatment compliance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.